Alpha1 antitrypsin and the prevalence and severity of asthma
- PMID: 14977698
- PMCID: PMC1719844
- DOI: 10.1136/adc.2002.023614
Alpha1 antitrypsin and the prevalence and severity of asthma
Abstract
In a random sample of children (aged 9-11 years; n = 5629), who were studied according to the ISAAC phase II protocol, heterozygosity of the alpha1 antitrypsin (alpha1-AT) Pi genotypes MS or MZ, or low alpha1-AT plasma levels, were not associated with an increased risk of developing asthma. Asthmatics with low levels of alpha1-AT were particularly prone to develop airway hyperresponsiveness and reduced lung function.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous